MiR-133a is a predictive biomarker in patients with metastatic colorectal cancer receiving oxaliplatin-based chemotherapy
Invited conference paper presented and published in conference proceedings

Full Text

Times Cited

Other information
Acceptance Date02/06/2018
All Author(s) ListNg SS, Dong Y, Leung WW, Ma BB, To KF, Sung JJ, Yu J
Name of ConferenceDigestive Disease Week 2018
Start Date of Conference02/06/2018
End Date of Conference05/06/2018
Place of ConferenceWashington, DC
Country/Region of ConferenceUnited States of America
Proceedings TitleGastroenterology
Volume Number154
Issue Number6 (Suppl 1)
Place of PublicationUSA
PagesS88 - S88
LanguagesEnglish-United Kingdom

Last updated on 2020-04-07 at 04:22